TERRY ROMANINI: Open Payments
NPI 1730519547 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 25 payments from 8 companies in 2025. Trend: 2023 $555 · 2024 $480 · 2025 $427
Food & beverage: $328Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $241 |
| GENZYME CORPORATION | 2 | $57 |
| ABBVIE INC. | 2 | $30 |
| UCB, Inc. | 2 | $29 |
| Lilly USA, LLC | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Organon LLC | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: TREMFYA, DUPIXENT, Bimzelx, EBGLYSS, CIBINQO, RINVOQ, VTAMA, COSENTYX.
Industry payments across OR — which companies pay providers there.
